Home Past Editions Milan 2025
Inaugural Edition · 2025

MaxPotent Pharma Summit Milan 2025

25–26 September 2025 · Duo Milan Porta Nuova, Milan, Italy. The summit that started it all. The inaugural edition set the template: regulatory compliance, containment technology, process optimisation, risk mitigation and occupational safety, with more than 50 companies represented across two days.

📍
Venue
Duo Milan Porta Nuova
Milan, Italy · 25–26 September 2025

Download the 2025 Post Event Report

Key Sessions from the Inaugural Summit

Toxicology Aspects in Worker and Patient Safety

Martin Kohan

Managing Toxicologist, SafeBridge Europe, UK

High Containment HPAPI Kilo Lab & Production Development Scale Plant

David Cragin

Senior Director, Occ & Env Health Sciences, EHS and Sustainability, Teva Pharmaceuticals

Cleaning Validation for HPAPI: One Driver to Prevent Cross-Contamination

Andreas Schreiner

Global Validation Leader, Novartis

Advanced HPAPI Containment Systems: Engineered to Handle CPTs Down to 1 ng

Stefano Butti

Technical Sales Director, FPS Pharma

Understanding European Regulatory Requirements for High-Containment Facilities

Giorgio Mari

Senior Process Engineer, Exyte

High Containment HPAPI Kilo Lab & Production Development Scale Plant

Andrew Lemaire

Technical Director of Containment & Micronization Technologies, DEC Group

From Compliance to Competitive Advantage: Embedding Sustainability Across the Pharma Value Chain

Matteo Alaria

Senior Sustainability Leader, former Head of Sustainability, Sartorius

Pre-Reconstruction Risk Evaluation for a Development API Plant: A Cross-Contamination and Containment Assessment

Dr. Ildikó Ziegler

Director of Quality, Hunazine Biotech S.L.

What the First Edition Established

Regulatory Compliance

Updates and insights into navigating HPAPI-specific regulations and global standards.

Containment Technologies

Latest innovations to ensure safe handling of high-potency compounds.

Process Optimisation

Best practices for efficient, scalable and risk-controlled manufacturing.

Risk Mitigation & Safety

Strategies for minimising exposure, ensuring worker safety and maintaining environmental compliance.

Networking & Collaboration

Opportunities to build partnerships and foster knowledge exchange among pharma innovators, CMOs/CDMOs and regulatory experts.

Market Insights

Understanding trends in HPAPI demand, technology adoption and growth projections.

Thought Leadership

Keynote sessions and panel discussions featuring industry leaders and subject-matter experts.

CDMO Insights

Strategies for CMOs/CDMOs to enhance operational efficiency, expand service offerings and collaborate with pharma innovators.

Who Should Attend

Seniority

From Pharmaceutical, Biopharmaceutical, and Contract Manufacturing organisations

Senior Managers Principal Scientists Principal Toxicologists Fellows Investigators Chief Executives Vice Presidents Directors Heads Leaders

Key departments

Validation Manufacturing / Operations / Production Occupational Toxicology Process Development / Technical Transfer Environmental, Health & Safety (HSE) Risk Assessments Product Quality Engineering Regulatory Affairs Formulation Development New Products Research & Development Industrial Hygiene Laboratory Services / Analytical New Technologies Maintenance

Who Backed the Inaugural Edition

Every organisation that has sponsored, exhibited or partnered across the MaxPotent series to date.

FPS Pharma & Food Systems
CSV Life Science Group
DEC Group
BSP Pharmaceuticals
CTS Europe
AM Instruments
Evonik
PQMS
Indena
Icrom
Esteve Química
Morpho by Alfasigma
Fareva
Minakem
WuXi AppTec
Olon
Watson-Marlow
Dipharma

Trusted by Industry Leaders

The event was exceptionally well organised, offering ample networking opportunities with a large number of attendees and presenters. The hospitality was excellent, and it was a pleasure to interact with colleagues while highlighting the importance of toxicology in areas such as containment, risk assessment, and both worker and patient protection. We look forward to collaborating with Convolign on future events as well.
Martin Kohan
Managing Toxicologist, SafeBridge Europe, UK
We truly felt we were at the right place. Over the past two days, we had insightful discussions around containment systems. The event brought together many customers, key manufacturers, and leading engineering companies, making it a great platform to exchange knowledge, information, and experience. We will definitely look forward to joining next year’s edition.
Stefano Butti
Technical Sales Director, FPS Pharma & Food Systems Srl
Congratulations to the entire team of Convolign Business Consulting for organising such a wonderful event. It was a perfect platform to gain insights into the key factors and technologies shaping high potent drug manufacturing. We also had excellent opportunities to network with peers and connect with new clients.
Andrea Confetti
Chairman, Dipharma Francis Srl
The event was highly informative, and we made some excellent industry contacts to introduce our systems to. The footfall was impressive, and the presentations were insightful. Overall, it was a great event for us, and we look forward to attending the next edition.
Mike Shemeld
Technical Sales Manager, CTS Europe
We had an excellent delegate turnout. The one-to-one meetings were very well organised and provided a great platform to connect with leaders from across various segments of HPAPI drug development. Truly a valuable opportunity for meaningful discussions and collaborations.
Roberto Furlan
Sales Manager, CSV Containment
I found the event very engaging, with a wide range of interesting topics covered. The venue was excellent, offering plenty of opportunities for networking, and the hospitality was truly remarkable.
Andrea Weiss
International Business Strategist, AM Instruments

Be Part of the Third Edition